DRUGMAKER OFFERS FREE DRUGS The Boehringer Ingelheim Cares Foundation Inc. is offering to provide Boehringer Ingelheim Pharmaceuticals' prescrip- tion medications free of charge to U.S. residents who can- not otherwise afford them. The program will be administered by the new foundation. To qualify, patients must lack pre- scription coverage under a private, government or employee insurance plan, be ineligible for Medicaid, and meet annual income restrictions equal to or lower than 200 percent of the federal poverty level -- $36,200 or less for a family of four. HIV/AIDS patients have slightly different income restrictions. The program does not include any co-pays or fees for participants. An application form is available by calling 800- 556-8317. Boehringer Ingelheim specializes in immunology and inflammatory disease research and its medi- cations focus on cardiovascular diseases, such as acute coronary disease and hypertension; inflammation-related disorders, such as arthritis and enlarged prostate; diseases of the central nervous system, such as stroke; respiratory diseases, and HIV/AIDS.